XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
COMMON STOCK AND EARNINGS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2024
COMMON STOCK AND EARNINGS PER SHARE  
Schedule of computation of earnings per share

Three Months Ended

    

March 31,
2024

    

March 31,
2023

Basic and Diluted Earnings:

Net Income (Loss) Attributable to Common Stockholders, Used in Basic EPS

$

4,655

$

(7,188)

Add Back: Effect of Dilutive Interest Related to 2025 Notes (1)

534

Net Income (Loss) Attributable to Common Stockholders, Used in Diluted EPS

$

5,189

$

(7,188)

Basic and Diluted Shares:

Weighted Average Shares Outstanding, Basic

22,551,241

22,704,829

Common Shares Applicable to Unvested Restricted Stock Using the Treasury Stock Method

554

Common Shares Applicable to Dilutive Effect of 2025 Notes (2)

3,505,857

Weighted Average Shares Outstanding, Diluted

26,057,652

22,704,829

Per Share Information:

Net Income (Loss) Attributable to Common Stockholders

Basic

$

0.21

$

(0.32)

Diluted

$

0.20

$

(0.32)

(1)

As applicable, includes interest expense, amortization of discount, amortization of fees, and other changes in net income or loss that would result from the assumed conversion of the 2025 Convertible Senior Notes effective January 1, 2022 due to the implementation of ASU 2020-06 which requires presentation on an if-converted basis. For the three months ended March 31, 2023, a total of $0.5 million of interest was not included, as the impact of the 2025 Notes, if-converted, would have been antidilutive to net income (loss) attributable to common stockholders for the period. For the three months ended March 31, 2024, a total of $0.5 million was included as the impact to earnings per share, if-converted, would have been dilutive to net income attributable to common stockholders for the period.

(2)

A total of 3.5 million shares representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were included in the computation of diluted net income per share attributable to common stockholders for the three months ended March 31, 2024, because they were dilutive to net income attributable to common stockholders for the period. A total of 3.2 million shares, representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were not included in the computation of diluted net income (loss) attributable to common stockholders for the three months ended March 31, 2023, because they were antidilutive to net income (loss) attributable to common stockholders for the period.